Pharmacokinetics and pharmacodynamics of voxelotor (GBT440) in healthy adults and patients with sickle cell disease
Hutchaleelaha, Athiwat, Patel, Mira, Washington, Carla, Siu, Vincent, Allen, Elizabeth, Oksenberg, Donna, Gretler, Daniel D., Mant, Timothy, Lehrer‐Graiwer, Josh
Published in British journal of clinical pharmacology (01.06.2019)
Published in British journal of clinical pharmacology (01.06.2019)
Get full text
Journal Article
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease
Howard, Jo, Hemmaway, Claire Jane, Telfer, Paul, Layton, D. Mark, Porter, John, Awogbade, Moji, Mant, Timothy, Gretler, Daniel D., Dufu, Kobina, Hutchaleelaha, Athiwat, Patel, Mira, Siu, Vincent, Dixon, Sandra, Landsman, Noel, Tonda, Margaret, Lehrer-Graiwer, Joshua
Published in Blood (25.04.2019)
Published in Blood (25.04.2019)
Get full text
Journal Article
Drug-Drug Interaction Potential of Mavacamten with Oral Contraceptives: Results from a Clinical Pharmacokinetic Study and a Physiologically Based Pharmacokinetic Model
Chiang, Manting, Sychterz, Caroline, Gaohua, Lu, Perera, Vidya, Gretler, Daniel D, Florea, Victoria, Merali, Samira
Published in Journal of clinical pharmacology (01.11.2023)
Published in Journal of clinical pharmacology (01.11.2023)
Get more information
Journal Article
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)
Turpie, Alexander G G, Bauer, Kenneth A, Davidson, Bruce L, Fisher, William D, Gent, Michael, Huo, Michael H, Sinha, Uma, Gretler, Daniel D
Published in Thrombosis and haemostasis (01.01.2009)
Published in Thrombosis and haemostasis (01.01.2009)
Get more information
Journal Article
Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)
Connolly, Stuart J, Eikelboom, John, Dorian, Paul, Hohnloser, Stefan H, Gretler, Daniel D, Sinha, Uma, Ezekowitz, Michael D
Published in European heart journal (01.05.2013)
Published in European heart journal (01.05.2013)
Get full text
Journal Article
Effects of Omeprazole and Verapamil on the Pharmacokinetics, Safety, and Tolerability of Mavacamten: Two Drug–Drug Interaction Studies in Healthy Participants
Perera, Vidya, Gretler, Daniel D., Seroogy, Julie D., Chiang, Manting, Palmisano, Maria, Florea, Victoria
Published in Clinical pharmacology in drug development (01.12.2023)
Published in Clinical pharmacology in drug development (01.12.2023)
Get full text
Journal Article
Recommendation of mavacamten posology by model‐based analyses in adults with obstructive hypertrophic cardiomyopathy
Merali, Samira, Salinger, David H., Palmisano, Maria, Sehnert, Amy J., Thanneer, Neelima, Back, Hyunmoon, Seroogy, Julie D., Gretler, Daniel D., Roy, Amit, Perera, Vidya
Published in CPT: pharmacometrics and systems pharmacology (01.09.2024)
Published in CPT: pharmacometrics and systems pharmacology (01.09.2024)
Get full text
Journal Article
Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration
Chang, Peter, Perera, Vidya, Salinger, David H., Merali, Samira, Thanneer, Neelima, Back, Hyunmoon, Seroogy, Julie D., Gretler, Daniel D., Sehnert, Amy J., Palmisano, Maria, Roy, Amit
Published in CPT: pharmacometrics and systems pharmacology (01.09.2024)
Published in CPT: pharmacometrics and systems pharmacology (01.09.2024)
Get full text
Journal Article
PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy Volunteers
Coffey, Greg, Rani, Aradhana, Betz, Andreas, Pak, Yvonne, Haberstock‐Debic, Helena, Pandey, Anjali, Hollenbach, Stanley, Gretler, Daniel D., Mant, Tim, Jurcevic, Stipo, Sinha, Uma
Published in Journal of clinical pharmacology (01.02.2017)
Published in Journal of clinical pharmacology (01.02.2017)
Get full text
Journal Article
Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y12 -receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI)
Leonardi, Sergio, MD, Rao, Sunil V., MD, Harrington, Robert A., MD, Bhatt, Deepak L., MD, MPH, Gibson, C. Michael, MS, MD, Roe, Matthew T., MD, Kochman, Janusz, MD, PhD, Huber, Kurt, MD, Zeymer, Uwe, MD, Madan, Mina, MD, MHS, Gretler, Daniel D., MD, McClure, Matthew W., MD, Paynter, Gayle E., RN, BS, Thompson, Vivian, MPH, Welsh, Robert C., MD
Published in The American heart journal (01.07.2010)
Published in The American heart journal (01.07.2010)
Get full text
Journal Article
First‐in‐Human Study of AG10, a Novel, Oral, Specific, Selective, and Potent Transthyretin Stabilizer for the Treatment of Transthyretin Amyloidosis: A Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Adult Volunteers
Fox, Jonathan C., Hellawell, Jennifer L., Rao, Satish, O'Reilly, Terry, Lumpkin, Rick, Jernelius, Jesper, Gretler, Daniel, Sinha, Uma
Published in Clinical pharmacology in drug development (01.01.2020)
Published in Clinical pharmacology in drug development (01.01.2020)
Get full text
Journal Article
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: The Early Rapid ReversAl of Platelet ThromboSis with Intravenous Elinogrel before PCI to Optimize REperfusion in Acute Myocardial Infarction (ERASE MI) pilot trial
Berger, Jeffrey S., MD, MS, Roe, Matthew T., MD, MHS, Gibson, C. Michael, MD, MS, Kilaru, Rakhi, MS, Green, Cynthia L., PhD, Melton, Laura, PhD, Blankenship, James D., MD, Metzger, D. Christopher, MD, Granger, Christopher B., MD, Gretler, Daniel D., MD, Grines, Cindy L., MD, Huber, Kurt, MD, Zeymer, Uwe, MD, Buszman, Pawel, MD, Harrington, Robert A., MD, Armstrong, Paul W., MD
Published in The American heart journal (01.12.2009)
Published in The American heart journal (01.12.2009)
Get full text
Journal Article
Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI)
Leonardi, Sergio, Rao, Sunil V, Harrington, Robert A, Bhatt, Deepak L, Gibson, C Michael, Roe, Matthew T, Kochman, Janusz, Huber, Kurt, Zeymer, Uwe, Madan, Mina, Gretler, Daniel D, McClure, Matthew W, Paynter, Gayle E, Thompson, Vivian, Welsh, Robert C
Published in The American heart journal (01.07.2010)
Published in The American heart journal (01.07.2010)
Get full text
Journal Article
ABSENCE OF QTC PROLONGATION WITH BETRIXABAN: A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND POSITIVE-CONTROLLED THOROUGH ECG STUDY
Sinha, Uma, Morganroth, Joel, Gretler, Daniel D, Hollenbach, Stanley J, Lambing, Joseph L
Published in Journal of the American College of Cardiology (12.03.2013)
Published in Journal of the American College of Cardiology (12.03.2013)
Get full text
Journal Article
Absence of QTc prolongation with betrixaban: a randomized, double-blind, placebo- and positive-controlled thorough ECG study
Morganroth, Joel, Gretler, Daniel D, Hollenbach, Stanley J, Lambing, Joseph L, Sinha, Uma
Published in Expert opinion on pharmacotherapy (01.01.2013)
Published in Expert opinion on pharmacotherapy (01.01.2013)
Get more information
Journal Article
Bridging the gap between clinical trials of antiplatelet therapies and applications among elderly patients
Dauerman, Harold L., MD, Bhatt, Deepak L., MD, MPH, Gretler, Daniel D., MD, French, Patricia A., BS, Smyth, Susan S., MD, PhD, Becker, Richard C., MD
Published in The American heart journal (01.04.2010)
Published in The American heart journal (01.04.2010)
Get full text
Journal Article
The Kinetics of Integrilin Limited by Obesity: A multicenter randomized pharmacokinetic and pharmacodynamic clinical trial
Vavalle, John P., MD, Stevens, Susanna R., MS, Hassinger, Nancy, MD, Cohen, Mauricio G., MD, Arnold, Anita, DO, Kandzari, David E., MD, Aguirre, Frank V., MD, Gretler, Daniel D., MD, Alexander, John H., MD, MHS
Published in The American heart journal (01.12.2011)
Published in The American heart journal (01.12.2011)
Get full text
Journal Article
KINETICS OF INTEGRILIN LIMITED BY OBESITY (KILO): A MULTI-CENTER RANDOMIZED CLINICAL TRIAL
Vavalle, John P, Stevens, Susanna, Hassinger, Nancy, Cohen, Mauricio G, Arnold, Anita, Kandzari, David E, Aguirre, Frank V, Gretler, Daniel D, Alexander, John H
Published in Journal of the American College of Cardiology (05.04.2011)
Published in Journal of the American College of Cardiology (05.04.2011)
Get full text
Journal Article